Tuesday 17 November 2020
Potential COVID-19 vaccines touted by pharmaceutical giants Pfizer and Moderna have upturned markets over the past 10 days, with investors flocking to stocks that might benefit from a potential return to normal life. In fact, companies in the S&P 500 have added more than $1 trillion to their market values since Pfizer’s announcement, and both the Dow and the S&P set new record highs directly following Moderna’s tease on Monday. Stocks hailing from the financials, industrials, and energy sectors have contributed the bulk of those gains so far, at least in terms of raw dollar value. (If the visualizations on this page…
This story continues at The Next Web
